Alexander McCampbell

Active Investor

Global Head of Neuroscience & Rare Diseases Research at Pharma Research & Early Development at Roche at Roche

Switzerland

Alexander McCampbell, Global Head of Neuroscience & Rare Diseases Research at Pharma Research & Early Development at Roche at Roche is an active investor based in Switzerland. This profile covers what Alexander McCampbell backs, at which stage, and how founders can reach out in 2026.

Investor type: VCInvestor
Stages: Seed
Invests in: Healthcare & BiotechDigital Health & HealthTechBiotech & PharmaMedTech & Medical DevicesSaaS & EnterpriseConsumer & RetailClimate & EnergyDeveloper Tools & Data
Location: Switzerland
Typical check: $250K

How to reach Alexander McCampbell

Angels and operators like Alexander McCampbell reply to specific, personalized notes that show real traction, not mass blasts. Build a verified list, write a note that fits their thesis, and track replies, all on Round Funded.

Frequently Asked Questions

What does Alexander McCampbell invest in?

Alexander McCampbell invests in Healthcare & Biotech, Digital Health & HealthTech, Biotech & Pharma and MedTech & Medical Devices, typically at Seed. Match your sector and stage, then reach out with a personalized pitch.

How do I contact Alexander McCampbell?

Unlock Alexander McCampbell's verified email on Round Funded and send a personalized pitch. We surface only deliverable contacts so your outreach lands.